Due to a production error, there was an error in the Article Title. The final “s” of “Challenges” was missed from the end of the title.
The publisher apologizes for this mistake. The original version of this article has been updated.
. 2021 Oct 7;12:782687. doi: 10.3389/fimmu.2021.782687
Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
Frontiers Production Office1,*
1Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
✉
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
Received 2021 Sep 24; Accepted 2021 Sep 24; Collection date 2021.
Keywords: glioblastoma, brain cancer, immunotherapy, tumor microenvironment, resistance to therapy
Copyright © 2021 Frontiers Production Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
PMCID: PMC8529955 PMID: 34691087
This corrects the article "Immunotherapy for Glioblastoma: Current Progress and Challenges", 676301.